Background
Introduction
Human head and neck carcinoma includes a heterogeneous group of malignancies of the oral cavity, oropharynx, hypopharynx, larynx, lips, paranasal sinuses and salivary glands [1] . More than 90% of these cancers are squamous cell carcinomas (HNSCC). HNSCC represents the sixth most common malignancy worldwide [2] . The major risk factors include tobacco and alcohol consumption, poor oral hygiene, and infection by human papillomavirus (HPV) [3] [4] [5] .
The majority of HNSCCs are diagnosed in locally advanced stages. Surgery, radiotherapy and chemotherapy are the current main strategies to treat HNSCC patients. Local recurrence remains the dominant pattern of treatment failure. Recent advances in the understanding of the molecular mechanisms of disease initiation and progression have led to the development of more specific therapies, such as Cetuximab, a monoclonal antibody against the epidermal growth factor receptor (EGFR). Cetuximab has been approved for combinational therapy with radiation in patients with unresectable HNSCC [6] . Overexpression of EGFR was often associated with a poor prognosis in HNSCC [7] . Although enhanced efforts have been put into effect and new therapies have been introduced during the last decade, the morbidity rate of HNSCC has not been reduced significantly [8] . A major challenge of current available therapies (radiation and chemotherapy) is the rapid development of resistance. Therefore, identification of cellular/molecular mechanisms responsible for resistance and development of new therapeutic strategies to overcome the resistance would improve the efficiency of current therapies.
Human immunodeficiency virus protease inhibitors (HIV PIs) are key components of highly active anti-retroviral therapy (HAART) for HIV infection. Previous studies from our laboratory and other laboratories demonstrated that HIV PIs are able to trigger the unfolded protein response (UPR) and endoplasmic reticulum (ER) stress [9, 10] . Three main branches of the UPR have been identified so far, including IRE1, PERK and ATF6 [11, 12] . PERK pathway activation is considered tightly correlated with cell apoptosis and survival. PERK activationinduced phosphorylation of eIF2α, a key mediator of protein translation, further disrupts translation initiation complexes and subsequently leads to global suppression of protein expression. Phosphorylation of eIF2α further induces the expression of ATF4, which leads to activation of CHOP, a proapoptotic factor [13] [14] [15] . Emerging evidence demonstrated that HIV PI-induced ER stress activation is linked to cell apoptosis in different types of cells [16] [17] [18] [19] [20] . Several studies reported that HIV PIs induced apoptosis through activating the STAT3/ERK1/ 2 pathway in human multiple myeloma cells and prostate cancer cells [21, 22] . HIV PIs are also able to induce cell cycle arrest and cell death by triggering the ER stress response [23, 24] . Recent studies further suggest that HIV PIs could be potential anti-cancer drugs due to their inhibitory effects on the PI3K-Akt signaling pathway, which is considered to be an important survival mechanism in various cancer cells [25] . Several preclinical studies indicated that down-regulation of Akt phosphorylation by HIV PI treatment or by the proteasome inhibitor, Bortezomib, resulted in increased radiosensitivity of cancer cells [20, 26, 27] . Despite the fact that HIV PIs have been identified as potential radio-sensitizers, the underlying mechanisms are still unclear. The current study was aimed at examining whether the most commonly used HIV PIs (lopinavir and ritonavir, L/R) are able to increase the radiosensitivity in HNSCC and further identify the underlying mechanisms for that increase.
Materials and Methods

Materials
HIV protease inhibitors, lopinavir (L) and ritonavir (R), were obtained from NIH AIDS Research & Reference Reagent Program, Division of AIDS, NIAID, NIH. Thapsigargin (TG) and dimethyl sulfoxide (DMSO) was purchased from Sigma-Aldrich (St. Louis, MO). Cell Counting Kit-8 (CCK-8) was from Dojindo Molecular Technologies (Kumamoto, Japan). Antibodies against p-ERK1/2, ERK1, ERK2, CHOP, ATP-4, XBP-1, Lamin B, p-eIF-2α, and eIF-2α were from Santa Cruz Biotechnology (Santa Cruz, CA). Mouse monoclonal antibody against β-actin and polyclonal antibodies against p-AKT, AKT, and cyclin D1 were from Thermo Scientific (Wilmington, DE). IRDye secondary antibodies were purchased from LI-COR Biosciences (Lincoln, NE). Bio-Rad protein assay reagent, Precision Plus Kaleidoscope Standards, iQTM SYBR Green Supermix were obtained from Bio-Rad (Hercules, CA). QIAzol Lysis Reagent was obtained from QIAGEN Sciences (Germantown, MD). High Capacity cDNA Reverse Transcription Kit was from Life Technologies (Grand Island, NY). Cell culture medium and supplement components were products from Invitrogen (Carlsbad, CA, USA)
Cell culture and treatment
Human HNSCC cells, FaDu hypopharyngeal cancer cell line (HTB-43) and SQ20B cell line, were obtained from ATCC. FaDu cells were cultured in MEM medium with 10% Fetal Bovine Serum, penicillin G (100 U/ml), streptomycin (100 μg/ml) and 1% non-essential amino acids (NEAA). SQ20B cells were cultured in RPMI 1640 medium with 10% Fetal Bovine Serum, penicillin G (100 U/ml) and streptomycin (100 μg/ml). HIV PIs (L/R, 4/1 ratio) and TG were dissolved in DMSO. Drugs were directly added into the cell culture medium and incubated for different periods as described previously [28] [29] [30] [31] . Perkin Elmer (Waltham, MA) was used to measure the absorbance at 450nm as described previously [32] .
Cell proliferation assay
Clonogenic survival assay
SQ20B and FaDu cells were cultured in 24-well plates with or without HIV PI treatment for 24 h and followed by irradiation with different doses, 2Gy or 4Gy. After 24 h, cells were detached and plated for colony-formation assays to assess clonogenic survival. Cells were cultured for 12 days, fixed in 10% formaldehyde, and stained with 0.5% violet crystal. Colonies containing 50 or more cells were counted to determine the surviving fractions of clonogenic cells using an Olympus microscope as described previously [33] .
Annexin V and Propidium Iodide (PI) staining
SQ20B and FaDu cells were cultured in 6 well plates. After 24h treatment, cells were harvested and resuspended into a density of 10 6 cells/ml. BD Pharmingen FITC Annexin V Apoptosis Detection Kit I (BD Science, San Diego, CA) was used to perform the staining, according to the protocol recommended by the manufacturer as described previously [30] . The stained cells were then analyzed by Cellometer Vision CBA Analysis System (Nexcelom Bioscience, Lawrence, MA).
Cell cycle assay 
RNA isolation and quantitative real-time RT-PCR
Cells were treated with HIV PIs or vehicle control for 24 h. Total Cellular RNA was isolated using QIAzol Lysis Reagent and reverse transcribed into first-strand cDNA using a HighCapacity cDNA Transcription Kit. The mRNA levels of ATF-4, XBP-1, CHOP, and GAPDH were quantified with real-time RT-PCR as described previously [16, 17, 19, 28-30, 34, 35] .
Western Blot analysis
The nuclear proteins and total proteins were isolated as previously described [16] . The protein levels of target genes were detected using specific primary antibodies and IRDye secondary antibodies on an Odyssey Fluorescence Imaging System (LI-COR Biosciences, USA) as described previously [19, 35, 36] . The density of the immunoblots was analyzed using Odyssey V3.0 software
Wound healing assays SQ20B cells were plated into 12-well plates at a concentration of 5 x 10 5 cells per well for overnight and allowed to form a confluent monolayer. After that the monolayer was scratched with a sterile pipette tip, cells were washed gently with serum free medium to remove floating and detached cells and photographed (time 0 h) using an Olympus 1x71 microscope using a 10 x objective. Cells were treated with different amounts of L/R (0-25 μM) or vehicle control (DMSO) or TG (100 nM). After 6h, the wounded area was photographed as described previously [32] . The images acquired for each treatment group were further analyzed using IPLab 4.0.
Statistical analysis
All of the experiments were repeated at least three times and the data were expressed as the mean ± SD. One-way ANOVA was employed to analyze the differences between sets of data.
To confirm the differences that occurred between groups, post hoc tests were used for followup tests. Statistics were performed using GraphPad Prism 5.0 (GraphPad, San Diego, CA) as described previously [32, 36] . A value of P<0.05 was considered statistically significant.
Results
Effect of HIV PIs on radiosensitivity of HNSCC cells
To 
Effect of HIV PIs on ER stress activation and cell apoptosis
Our previous studies have shown that HIV PIs induce ER stress and cell apoptosis in macrophages, hepatocytes, intestinal epithelial cells, and adipocytes [16, 18, 19, 34] . To examine whether L/R also activates ER stress in HNSCC cells, we first examined the effect of L/R on mRNA expression of the key genes involved in the UPR. As shown in Fig 3, L/R dosedependently increased CHOP, ATF-4, and XBP-1 mRNA levels in both SQ20B and FaDu cells. TG was the positive control for ER stress induction. As shown in Fig 4 , L/R-induced mRNA expression of the UPR genes was correlated to up-regulation of the corresponding protein level. L/R had a more profound effect on ATF-4 expression. To further determine whether L/R-induced UPR activation was able to promote cell apoptosis, Annexin V-PI staining was used to detect apoptotic and necrotic cells after treatment with L/R (25 μM) or TG (50 nM) for 24 h. 
Effect of HIV PIs on HNSCC cell migration
Cancer cells spread from the initial site of tumor growth by first invading the surrounding tissue (migration). The ability of tumor cells to migrate is closely linked to tumor growth and invasiveness. To determine the effect of HIV PIs on HNSCC cell migration, we did a wound healing assay in SQ20B cells as described in Methods. As shown in Fig 6 , L/R dose-dependently inhibited cell migration. Similar results were obtained with TG, the ER stress inducer.
Effect of HIV PIs on cell cycle distribution
In order to identify the potential mechanisms underlying HIV PI-induced radiosensitivity of HNSCC, we examined the effect of L/R on cell cycle distribution. After treatment with L/R (25 μM) or TG (50 nM) for 24h, cells were analyzed using the Cellometer PI Cell Cycle Kit from Nexcelom. As shown in Fig 7, L/R significantly increased SQ20B and FaDu cells at G0/G1 phase and cells at S/G2 phases were markedly decreased. These results indicated that L/R increased radiosensitivity of SQ20B and FaDu cells through inducing G 0 /G 1 phase arrest rather than promoting apoptosis. Overexpression of EGFR is detected in 90% of HNSCC. EGFR-mediated activation of PI3K/ Akt and mitogen-activated/extracellular signal-regulated kinase (MEK) contributes to activation of NF-ƙB and induction of inflammatory response. Activation of Akt also induces activation of the mammalian target of rapamycin (mTOR). Emerging evidence indicates that phosphorylated Akt plays an important role in radio-resistance in cancer cells [37] [38] [39] . It also has been reported that the HIV PI, nelfinavir, has an inhibitory effect on Akt activation and mTOR [26, 27] . To determine whether L/R have any effect on Akt activation in HNSCC, we measured the phosphorylation level of Akt in SQ20B and FaDu cells after treatment with L/R for 24 h by western blot analysis. The results indicated that L/R had no significant effect on Akt activation in HNSCC (Data not shown).
Effect of HIV PIs on the expression of cyclin D1
HNSCC exhibits increased expression of cyclin D1, a key moderator in cell cycle progression from G 1 phase to S phase. Overexpression of cyclin D1 correlates to poor prognosis of HNSCC [40] . It has been shown that ER stress-mediated activation of the PERK/eIF2α/ATF-4 signaling pathway down-regulated expression of cyclin D1 by suppressing global protein synthesis. To further identify the mechanism underlying HIV PI-induced cell cycle arrest in HNSCC, we examined the effect of HIV PIs on PERK/eIF2α activation and cyclin D1 expression. As shown in Fig 8A and 8B , L/R dose-dependently increased the protein levels of phosphorylated eIF2α (p-eIF2α) in both SQ20B and FaDu cells. Furthermore, L/R-induced increase of p-eIF2α was correlated to the decrease of cyclin D1 protein levels (Fig 8C) , suggesting the contribution of activation of ER stress to HIV PI-enhanced radiosensitivity of SQ20B and FaDu cells.
Discussion
HNSCC is still a devastating malignancy worldwide. The overall five-year survival rate is only about 50% despite recent advances in therapy. Radiotherapy is the cornerstone of current therapy for HNSCC. The major challenge to the management of HNSCC is the rapid development of resistance to radiotherapy [41] . HIV PIs have been successfully used to inhibit HIV replication and have significantly reduced the morbidity and mortality of HIV patients in the past two decades. Several studies have reported that HIV PIs, such as nelfinavir, can increase the radiosensitivity of certain cancer cells including HNSCC [20-23, 27, 42-44] . However, the toxicity of nelfinavir is relatively higher than other HIV PIs and the underlying mechanisms still remain unknown. In the present study, we investigated the effects of the most commonly used HIV PIs, L/R, on cell proliferation, migration, and radiosensitivity of HNSCC and further identified the potential mechanisms. The results indicated that L/R significantly inhibited cell growth and migration, and markedly enhanced radiosensitivity. Previous studies from our groups and others' suggested that HIV PIs induce ER stress and apoptosis in different types of cells [18] [19] [20] 45] . It has been reported that ER stress sensitizes cancer cells to radiation [46, 47] . Although L/R did not directly induce apoptosis in HNSCC cells, radiosensitivity was significantly enhanced after pretreatment with L/R. Several studies have reported that nelfinavir sensitized HNSCC cells to radiation mainly by inhibiting the PI3/Akt signaling pathway [27] . The Ras/PI3K/Akt signaling pathway is considered to be an important radio-resistance pathway in cancer cells because of modulation of cell cycle progression, especially at the G 1 /S transition, and DNA damage repair after radiation exposure [24, [37] [38] [39] 48] . Cells under G 1 phase prepare proteins and enzymes for the following DNA synthesis in S phase. The formation of two critical complexes, Cyclin D1/CDK4 and Cyclin E/CDK2, is the core mechanism of cell cycle progression from G 1 to S phase. Akt is an important regulator of the activation of cyclin D1 and inhibition of P27kip1, a suppresser of the cyclin D1/CDK4 complex, and induces cell proliferation by promoting cells to pass through the G 1 checkpoint [49, 50] . In addition, Akt also increases cancer cell survival after radiation by helping to repair radiation-induced DNA damage [51] . These findings suggested that targeting Akt represents a promising new anti-cancer therapy. However, inhibition of the Akt-signaling pathway alone is not enough to enhance radiosensitivity of HNSCC [27] . In contrast to nelfinavir, which required longer (3-day) treatment, L/R only required a shorter (1-day) treatment to enhance radiosensitivity of HNSCC cells. Also, L/R had no effect on Akt activation, suggesting that another Akt-independent pathway is involved in L/R-mediated radio-sensitization.
ER stress-mediated activation of the UPR has been implicated in cell growth arrest and inhibition of cell migration. In the current studies, we identified that L/R significantly activated the IRE1α/XBP1 and PERK/eIF2α/ATF4 in SQ20B and FaDu cells. Although L/R significantly upregulated CHOP, a proapoptotic factor, there was no significant change in terms of cell apoptosis. These results suggest that an L/R-mediated increase of radiosensitivity of HNSCC cells is independent of suppression of Akt activation and induction of apoptosis.
Regulation of cell cycle checkpoints is important for cell growth. Our results indicated that L/R significantly arrested SQ20B and Fadu cells at the G 0 /G 1 phase. Previous studies have shown that ER stress-mediated activation of PERK/eIF2α was correlated to the down-regulation of cyclin D1 by global translation suppression [52, 53] . Overexpression of PERK also induced significant reduction of CDK2 activity [53] . In addition, crosstalk between PERK-induced eIF2α phosphorylation and cyclin D1 protein degradation was reported recently [54] . Our studies also showed that L/R-mediated activation of the PERK/eIF2α pathway was linked to G 0 /G 1 cell cycle arrest and down-regulation of cyclin D1 protein levels in SQ20B and FaDu cells. During the last decade, several chemotherapeutic agents, which induce cell cycle arrest, such as flavopiridol and paclitaxel, have been used to enhance radiosensitivity of cancer cells [55] . Our studies suggest that the HIV PIs, L/R, can be used to treat HNSCC in combination with other chemotherapies and radiotherapy.
Conclusions
In summary, our study demonstrated that administration of HIV PIs (L/R) significantly enhanced radiosensitivity of SQ20B and FaDu cells. As illustrated in Fig 9, L/R induced activation of the ER stress response and subsequently activated PERK/eIF2α/ATF-4 and reduced cyclin D1 protein levels. L/R induced cell cycle arrest mainly through the inhibition of global protein translation and cell growth. Our studies suggest that activation of ER stress response represents one of the key mechanisms underlying HIV PI-induced radiosensitivity. This study provides a rationale for clinical investigation of the combination therapy using the FDA-approved HIV PIs (L/R) with radiotherapy in patients with HNSCC.
